NASDAQ NMS - GLOBAL MARKET · PLRX
+0.00% · +$0.0000 · Vol 310.4K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
Pliant Therapeutics Inc

Pliant Therapeutics Inc

Pharmaceuticals
$1.05
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
PLRX
Pliant Therapeutics Inc
Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

63/ 100
Veridion Score
BUY BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 7 · market closed · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is PLRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading PLRX catalysts
About Pliant Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2020
Employees
49
Country
US

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.05
Day high
$1.07
Day low
$1.03
Previous close
$1.05
52W high
$1.87
-43.85% from high
52W low
$1.03
2% of range
Market cap
$65M
EPS
$-2.3800
Beta
0.51
Shares out
61.9M
Volume
310.4K
0.55× rel vol
Avg volume
567.9K
VWAP
$1.05
Price history computed in-house
1W
+0.96%
1M
-7.08%
3M
-13.93%
1Y
-36.75%
YTD
-13.93%
SMA 50 $1.13 · below
SMA 200 $1.28 · below
52W position 2%

PLRX overview

Veridion Score
63
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around PLRX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading PLRX Form 4 filings
Public disclosures

Congress activity in PLRX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for PLRX in the cached public ledger.

Federal contracts

PLRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PLRX in this window.
Lobbying spend

PLRX lobbying filings, year to date.

Registered lobbying filings matched to Pliant Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PLRX in this window.
Loading news for PLRX
Analyst ratings
Sovereign unlock shows live analyst consensus for PLRX.
Options
Sovereign unlock shows live options positioning for PLRX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.